We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Axsome Therapeutics, Inc. (NASDAQ:AXSM) stands against the ...

Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Axsome Therapeutics in a research report issued ...

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

周三 - Needham分析师将Axsome Therapeutics (NASDAQ: AXSM )的目标股价从133.00美元上调至153.00美元，同时维持买入评级。该股今年以来表现强劲，涨幅超过51%，目前交易价格接近52周高点134.19美元。此次调整是在Axsome发布2024年第四季度财报后做出的，这份财报被描述为平淡无奇，特别是考虑到公司此前已在1月份的J.P.

周一，美银美林证券对Axsome Therapeutics (NASDAQ: AXSM )表现出看好态度。该公司目前股价为106.46美元，市值51.6亿美元。分析师Graig Suvannavejh将公司目标价从之前的122美元上调至137美元，同时维持对该股票的优于大市评级。此次调整是在Axsome的偏头痛药物AXS-07/Symbravo最近获得批准后做出的。根据 InvestingPro ...

$AXSM insiders have traded $AXSM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

In this article, we are going to take a look at where Axsome Therapeutics, Inc. (NASDAQ:AXSM) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze ...

Below is Validea's guru fundamental report for AXSOME THERAPEUTICS INC (AXSM). Of the 22 guru strategies we follow, AXSM rates highest using our Value Investor model based on the published ...

Shares of Axsome Therapeutics ( AXSM -0.40%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a commercial-stage biopharmaceutical company that develops and delivers therapies for central nervous system (CNS) conditions with limited treatment options.

Shares of Axsome Therapeutics (NASDAQ: AXSM) are up on Tuesday. The jump comes as the S&P 500 (SNPINDEX: ^GSPC) lost 0.3% and ...